Skip to main content


2021 Virtual Experience
The Official Partner of the Oncology Clinical Pathways Congress
The meeting focused on improving cancer care quality through clinical pathways.
Our 2021 Congress has Concluded, Join Us When We Return to Boston in 2022

Registration is now open for the 2022 Congress taking place October 14-16. The landscape of cancer care is rapidly evolving, and oncology pathways play a critical role in defining how we treat our patients. This meeting, which is the official congress of the Journal of Clinical Pathways, serves as a forum for those involved in all stages of the pathway development process to ask questions, learn how to measure outcomes, and explore ways to partner and expand pathway programs.

What to Expect

The Oncology Clinical Pathways Congress is a one-of-a-kind opportunity for all of those in the cancer care field to come together and make a positive impact on the future of patient care.


Leading Cancer Organizations
Expert Presenters
Unmatched Educational Sessions
Months of On-Demand Access
Meet the Steering Committee
Robin T. Zon, MD, FACP, FASCO
Past Chair, ASCO Pathways Task Force
President, Finance & Quality Chair
Michiana Hematology-Oncology, PC
Mishawaka, Indiana
Alan Balch, PhD
Chief Executive Officer
Patient Advocate Foundation
Hampton, Virginia
Wui-Jin Koh, MD
Senior Vice President, Chief Medical Officer
National Comprehensive Cancer Network
Ft. Washington, Pennsylvania
Frederick M. Schnell, MD, FACP
Chief Medical Officer
Community Oncology Alliance
Washington, DC
Stephen B. Edge, MD, FACS, FASCO
Vice President, Healthcare Outcomes & Policy, Professor of Surgery and Oncology, Department of Surgical Oncology, Breast Service, Roswell Park Comprehensive Cancer Center, Professor of Surgery, Jacobs School of Medicine, University at Buffalo, Buffalo, New York
Mahek A. Shah, MD, MBA, MS
Physician Executive and Advisor
Harvard Business School
Associate Faculty
Harvard School of Public Health and Brigham Health
Boston, Massachusetts
Network With Pathway Pioneers

This is your chance to learn best practices and common pitfalls from those who have experienced the sourcing, design, implementation, and evaluation process through:

• Case-Based Presentations
• Roundtable Discussions
• Networking Activities

Who Should Attend?

This program is designed for health-care professionals interested in learning how to implement, maintain, and measure treatment pathways.

Cancer Center Directors
Directors of Oncology Practice Programs
Oncologist & Hematologists
Pathway Development Executives
Commercial & Government Payers
Reimbursement Specialists
Specialty Pharmacists
HEOR Specialists
Nurse Navigators
Students, Residents & Fellows
I think this is the best conference of it's kind as it relates to clinical pathways on the road to value-based care."

Dr. Frederick Schnell
Chief Medical Officer
Community Oncology Alliance

This meeting is a great place for clinicians to be interactive with their peers and to learn about the latest advances in not only pathways and their development but also how they're used in a practice setting."

Gordon Kuntz

A ‘cookie cutter’ approach to cancer care will impede our ability to personalize care and meet patient needs. Pathways need to demonstrate flexibility to capitalize on advances in medical treatment, reflect development with scientific evidence, and assure providers that they offer the best possible outcomes for the patient."

Robin Zon, MD, FACP, FASCO
Chair, ASCO Pathways Task Force